Table 5.

Visual acuity change from visual acuity at initial visit to 3 months, 6 months, and 1 year from first visit

Time from first visit /Initial Visual Acuity	Steroid started ≤2 weeks from onset (n=261 eyes)			Steroid started >2 weeks from onset (n=101 eyes)
	n**	Number (%) of eyes		n**	Number (%) of eyes
		Improved	Worsened		Improved	Worsened
3 months*	(n=261)			(n=101)
20/15–20/30	140	—	20 (14%)	47	—	4 (9%)
20/40	22	1 (5%)	2 (9%)	11	0 (0%)	0 (0%)
20/50–20/60	29	5 (17%)	0 (0%)	15	0 (0%)	0 (0%)
20/70–20/100	26	9 (35%)	1 (4%)	8	2 (25%)	0 (0%)
20/200–20/400	11	7 (64%)	0 (0%)	4	0 (0%)	0 (0%)
Counting fingers or worse	33	17 (52%)	0 (0%)	16	4 (25%)	0 (0%)
20/70 or worse	70	33 (47%)	1 (1%)	28	6 (21%)	0 (0%)
6 months*	(n=244)			(n=94)
20/15–20/30	129	—	21 (16%)	43	—	6 (14%)
20/40	19	3 (16%)	2 (11%)	11	2 (18%)	0 (0%)
20/50–20/60	29	10 (34%)	1 (3%)	14	4 (29%)	1 (7%)
20/70–20/100	25	12 (48%)	1 (4%)	7	4 (57%)	1 (14%)
20/200–20/400	11	11 (100%)	0 (0%)	4	1 (25%)	0 (0%)
Counting fingers or worse	31	23 (74%)	1 (3%)	14	10 (71%)	0 (0%)
20/70 or worse	67	46 (69%)	2 (3%)	25	15 (60%)	1 (4%)
1 year*	(n=222)			(n=83)
20/15–20/30	120	—	22 (18%)	40	—	6 (15%)
20/40	15	3 (20%)	2 (13%)	9	3 (30%)	0 (0%)
20/50–20/60	26	10 (38%)	1 (4%)	13	5 (38%)	1 (8%)
20/70–20/100	22	12 (55%)	1 (5%)	6	4 (67%)	1 (17%)
20/200–20/400	11	10 (91%)	1 (9%)	4	2 (50%)	0 (0%)
Counting fingers or worse	28	20 (71%)	0 (0%)	11	8 (73%)	0 (0%)
20/70 or worse	61	42 (69%)	2 (3%)	21	14 (67%)	1 (5%)

^*±6 weeks for 3 and 6 months; ±12 weeks for 1 year

^**n includes the eyes that have a follow-up for visual acuity of at least the lower limit specified